-
Lexington doctor among the first to offer new treatment to those going blind
28 Mar 2024 13:27 GMT
… iDose, developed by Glaukos, was approved by the Federal Drug Administration … time.”
The treatment helps those diagnosed with Glaucoma. A microscopic … the common form of treatment—eye drops—and lessens … first to offer the treatment in the Bluegrass state, …
-
‘365 breathing’ increases parasympathetic activity, reduces IOP in patients with glaucoma
27 Mar 2024 22:27 GMT
… trial of 80 patients with early to moderate primary open-angle glaucoma … along with pharmacological glaucoma treatment and 40 controls continued only glaucoma treatment. The researchers … changes won’t replace medication or surgical intervention, they …
-
5 Weight-Loss Medications That Don't Require an Injection
27 Mar 2024 11:26 GMT
… available, this medication is only FDA-approved for those … .ae0fcc31ae342fd3a1346ebb1f342fcb
"These drugs have revolutionized my practice … clinically meaningful treatment response to the drug, defined as … overactive thyroid gland or glaucoma. It also isn…
-
MediciNova Receives a Notice of Allowance for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in Japan
26 Mar 2024 23:00 GMT
… MN-166 (ibudilast) for treating macular injury associated with … positive data from a glaucoma animal model study and … late-stage clinical development for the treatment of neurodegenerative diseases … the adequacy of clinical trial designs or the execution …
-
Successful Management of Bilateral Uncontrolled Advanced Primary Open Angle Glaucoma in a Pregnant Woman during the Restrictive COVID-19 Lockdown
26 Mar 2024 20:33 GMT
… Society Public Affairs Committee. FDA classification of drugs for teratogenic risk. Teratology … Razeghinejad MR, Nowroozzadeh MH. Anti-glaucoma medication exposure in pregnancy: an observational … LW, Brandt JD, Budenz DL. Treatment outcomes in the tube versus …
-
Center For Sight Implants New FDA-Approved iDose®TR Device
26 Mar 2024 20:30 GMT
… approved by the Food and Drug Administration in December, 2023. … principal investigator in the iDoseTR FDA Phase II and III … implant is a revolutionary treatment for our glaucoma patients as it … longer an issue when the medication is already implanted into …
-
Active Pharmaceutical Ingredient CDMO Market Size, Share & Trends Analysis Report 2024: Rapid Expansion Fueled by API Complexity and Cost Reduction Needs - Global Forecast to 2030 - ResearchAndMarkets.com
26 Mar 2024 13:25 GMT
… increase in demand for medications required to manage critically … of biopharmaceuticals in the treatment of chronic and … of pharmaceutical companies and contract manufacturing organizations in developing countries … Hormonal
7.4.3. Glaucoma
7.4.4. Cardiovascular …
-
Why are Black people more likely to develop glaucoma? Penn scientists discovered new clues in the largest study of its kind.
26 Mar 2024 09:52 GMT
… clues as to why glaucoma disproportionately affects Black people. … be used to develop better treatments and identify people … development of better drugs, O’Brien said. Currently, physicians treat … patients’ eyes, first with medication and later, if needed, …
-
Minimally Invasive Glaucoma Surgery: What options are there and when might they be considered?
25 Mar 2024 16:43 GMT
… alone. Significantly fewer glaucoma medications were required in the treatment group at two … al. Prospective Randomized, Controlled Pivotal Trial of an Ab Interno Implanted … Administration of Travoprost to Treat Open Angle Glaucoma. 31st Congress of the …
-
Translational Vision Science and Technology Journal Publishes RadiusXR's NOVA Clinical Trial, Demonstrating Industry-Leading Accuracy and Innovation in Visual Field Testing for Virtual Reality Perimetry
25 Mar 2024 12:24 GMT
… demonstrated through a clinical trial that shows statistical noninferiority … developed Micro-Invasive Glaucoma Surgery (MIGS) as an alternative to the traditional glaucoma treatment … platforms to support ongoing pharmaceutical and medical device innovations. …